About biomodal

biomodal develops the duet multiomics solution, a breakthrough technology that captures both genetic and epigenetic information from a single DNA sample in one sequencing run. The platform distinguishes all six bases of the genome, including 5-methylcytosine and 5-hydroxymethylcytosine, which current technologies cannot reliably separate at low sample inputs. This capability transforms research in cancer diagnostics, neurodegenerative disease, liquid biopsy, and precision medicine by revealing disease-relevant changes that conventional sequencing misses. Scientists and clinical developers gain access to multimodal biological insights that advance early detection, treatment development, and patient monitoring.